Ardent Health, Inc. (NYSE:ARDT) Given Consensus Rating of “Hold” by Brokerages

Shares of Ardent Health, Inc. (NYSE:ARDT) have received a consensus rating of “Hold” from the fourteen ratings firms that are currently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $13.0455.

A number of analysts have weighed in on the stock. Truist Financial raised their target price on shares of Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Wall Street Zen downgraded shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Weiss Ratings downgraded Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday. Guggenheim raised their price objective on Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $13.00 target price on shares of Ardent Health in a report on Thursday, August 6th.

Insider Activity at Ardent Health

In other news, CFO Alfred Lumsdaine purchased 10,000 shares of Ardent Health stock in a transaction dated Friday, June 5th. The shares were bought at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares in the company, valued at approximately $2,900,102.23. This trade represents a 3.13% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.90% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in Ardent Health during the 2nd quarter worth approximately $21,415,000. Goldentree Asset Management LP raised its stake in shares of Ardent Health by 99.7% during the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock valued at $20,302,000 after acquiring an additional 1,150,000 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after acquiring an additional 724,841 shares during the last quarter. Ameriprise Financial Inc. raised its stake in shares of Ardent Health by 75.6% during the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after acquiring an additional 703,739 shares during the last quarter. Finally, Algert Global LLC lifted its holdings in shares of Ardent Health by 1,277.3% during the second quarter. Algert Global LLC now owns 597,745 shares of the company’s stock worth $5,882,000 after purchasing an additional 554,345 shares during the period.

Ardent Health Stock Down 1.0%

ARDT stock opened at $10.98 on Friday. The firm has a 50-day moving average price of $10.16 and a 200-day moving average price of $9.57. Ardent Health has a 12 month low of $7.71 and a 12 month high of $15.48. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $1.55 billion, a P/E ratio of 19.97, a price-to-earnings-growth ratio of 3.19 and a beta of 0.70.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). The company had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.45%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, equities research analysts anticipate that Ardent Health will post 0.95 EPS for the current fiscal year.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.